Efficacy and Safety of Everolimus with Reduced Tacrolimus in Living-Donor Liver Transplant (LDLT) Recipients with Hepatocellular Carcinoma: Subgroup Analysis from the H2307 Study

被引：0

作者：

Jeng, L. -B. ^{[1
]}

Lee, S. -G. ^{[2
]}

Lee, W. -C. ^{[3
]}

Suh, K. -S. ^{[4
]}

Joo, D. J. ^{[5
]}

Joh, J. ^{[6
]}

Kaido, T. ^{[7
]}

Lopez, P. ^{[8
]}

Kochuparampil, J. ^{[8
]}

Kaneko, S. ^{[9
]}

Levy, G. ^{[10
]}

机构：

[1] China Med Univ Hosp, Taichung, Taiwan

[2] Asan Med Ctr, Seoul, South Korea

[3] Chang Gung Mem Hosp, Taoyuan, Taiwan

[4] Seoul Natl Univ Hosp, Seoul, South Korea

[5] Yonsei Univ, Coll Med, Severance Hosp, Seoul, South Korea

[6] Samsung Med Ctr, Seoul, South Korea

[7] Kyoto Univ Hosp, Kyoto, Japan

[8] Novartis Pharma AG, Basel, Switzerland

[9] Novartis Pharma KK, Tokyo, Japan

[10] Univ Toronto, Toronto, ON, Canada

来源：

TRANSPLANTATION | 2017年 / 101卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

LB P-19

引用

页码：375 / 376

页数：2

共 50 条

[1] Efficacy and Safety of Everolimus With Reduced Tacrolimus in Living-Donor Liver Transplant Recipients: Baseline Data from the H2307 Study
Levy, G.
Suh, K. S.
Joh, J. W.
Yoshizumi, T.
Lee, W. C.
Genyk, Y.
Grant, D.
Martzloff, E. -D.
Sips, C.
Wang, Z.
Lopez, P.
TRANSPLANTATION, 2015, 99 : 150 - 150
[2] EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED TACROLIMUS IN LIVING-DONOR LIVER TRANSPLANT RECIPIENTS WITH HEPATOCELLULAR CARCINOMA: SUBGROUP ANALYSIS FROM THE H2307-STUDY (NCT01888432)
Settmacher, U.
Braun, F.
Lopez, P. M.
Kochuparampil, J.
Lieb, S.
TRANSPLANT INTERNATIONAL, 2017, 30 : 27 - 27
[3] EVEROLIMUS WITH REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN LIVING-DONOR LIVER TRANSPLANT RECIPIENTS: BASELINE DATA FROM THE H2307 STUDY
Lopez, Patricia
Levy, Gary
Jeng, Long-Bin
Suh, Kyung Suk
Joo, Dong Jin
Lee, Sung Gyu
Lee, Wei-Chen
Chen, Chao-Long
Soin, Arvinder Singh
Joh, Jae Won
Yoshizumi, Tomoharu
Grant, David
Martzloff, El-Djouher
Sips, Carole
Wang, Zailong
TRANSPLANT INTERNATIONAL, 2015, 28 : 459 - 459
[4] EVEROLIMUS WITH REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN LIVING-DONOR LIVER TRANSPLANT RECIPIENTS: BASELINE DATA FROM THE H2307 STUDY
Settmacher, U.
Braun, F.
Sips, C.
Dong, G.
Kroeger, I.
Sanchez, J. Aguilar
TRANSPLANT INTERNATIONAL, 2015, 28 : 32 - 32
[5] EVALUATING THE EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN LIVING DONOR LIVER TRANSPLANT RECIPIENTS: H2307 STUDY DESIGN
Sips, C.
Suh, K. S.
Joh, J. W.
Yoshizumi, T.
Lee, W. C.
Genyk, Y.
Martzloff, E. -D.
Wang, Z.
Lopez, P.
Grant, D.
JOURNAL OF HEPATOLOGY, 2015, 62 : S858 - S859
[6] Safety and Efficacy Profile of Everolimus With Reduced Tacrolimus in Living Donor Liver Transplant Recipients-12-month Results From the Pivotal H2307 Study
Maluf, Daniel
Jeng, Long-Bin
Lee, Sung Gyu
Soin, Arvinder S.
Lee, Wei Chen
Emond, Jean
Lim, Kieron B.
Lopez, Patricia M.
Kochuparampil, Jossy
Sips, Carole A.
Kaneko, Shuhei
Grant, David
HEPATOLOGY, 2017, 66 : 901A - 901A
[7] DESIGN OF THE H2307 STUDY: EVEROLIMUS WITH REDUCED TACROLIMUS IN LIVING DONOR LIVER TRANSPLANTATION
Junge, Guido
Song, Gi-won
Joh, J. W.
Pomfret, E.
Lopez, Patricia M.
Hexham, J. M.
Uemoto, Shinji
Suh, K. S.
Levy, Gary
TRANSPLANT INTERNATIONAL, 2013, 26 : 299 - 299
[8] Effect of everolimus plus reduced-dose tacrolimus in de novo living-donor liver transplantation recipients on recurrence of HCC: 24 months subgroup analysis from the H2307 study
Jeng, L. -B.
Lee, S. -G.
Soin, A. S.
Lee, W. -C.
Suh, K. -S.
Joo, D. J.
Uemoto, S.
Meier, M.
Kochuparampil, J.
Sips, C.
Kaneko, S.
Levy, G.
TRANSPLANTATION, 2018, 102 : 300 - 301
[9] EVEROLIMUS WITH REDUCED TACROLIMUS PROVIDES COMPARABLE EFFICACY VS. STANDARD TACROLIMUS FOLLOWING LIVING DONOR LIVER TRANSPLANTATION: A 12-MONTH SUBGROUP ANALYSIS FROM THE PIVOTAL H2307 STUDY
Jeng, Long-Bin
Lee, Sung-Gyu
Soin, Arvinder Singh
Lee, Wei-Chen
Tokat, Yaman
Lim, Kieron B.
El Meteini, Mahmoud
Lopez, Patricia
Kochuparampil, Jossy
Sips, Carole
Kaneko, Shuhei
Yagi, Takahito
TRANSPLANT INTERNATIONAL, 2017, 30 : 65 - 65
[10] Renal Function and HCC Recurrence As Well As Safety of Everolimus with Reduced Tacrolimus Versus Standard Tacrolimus in Deceased and Living Donor Liver Transplant Recipients: Pooled Analysis of H2304 and H2307 Studies
Lee, Sung Gyu
Jeng, Long Bin
Saliba, Faouzi
Soin, Arvinder Singh
Lee, Wei-Chen
De Simone, Paolo
Nevens, Frederik
Suh, Kyung-Suk
Fischer, Lutz
Joo, DongJin
Fung, John J.
Joh, Jae-Won
Kaido, Toshimi
Grant, David R.
Meier, Matthias
Barbara, Rauer
Sips, Carole
Kaneko, Shuhei
Levy, Gary A.
HEPATOLOGY, 2018, 68 : 6A - 6A

← 1 2 3 4 5 →